CYP17 inhibitors are primarily used to treat prostate cancer. These medications work by blocking an enzyme called CYP17, which is involved in the production of hormones like testosterone. By inhibiting this enzyme, CYP17 inhibitors help reduce the levels of these hormones. This helps slow the growth of hormone-sensitive tumors. These medications are available in oral forms, and one example is abiraterone (Zytiga, Yonsa).
